CD cobas Reagents: payments to doctors
Payments that named CD cobas Reagents as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $507K
- Providers
- 357
- Transactions
- 767
- Average per transaction
- $662
The per-transaction average — $662 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 357 providers the average total is $1,421, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Roche Diagnostics Corporation | $466,288 | 91.9% |
| Roche Diagnostics Operations, Inc. | $38,363 | 7.6% |
| Roche Diagnostics International Ltd | $2,800 | 0.6% |